Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factor XIII in Systemic Sclerosis
NCT02551042Phase 2Unknown
- Sponsor
- University College London
- Start
- Sep 2015
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Factor XIII (human) in systemic sclerosis (SSc), sponsored by University College London. Primary endpoint: Modified Rodnan Skin Score at 24 weeks. Status: unknown.
02
Drugs
Factor XIII (human)
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT02551042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02551042.